Pre-Eclampsia Screening in Pregnancy

Total Page:16

File Type:pdf, Size:1020Kb

Pre-Eclampsia Screening in Pregnancy Victorian Clinical Genetics Services Arranging screening for Murdoch Children's Research Institute early onset pre-eclampsia Flemington Road, Parkville VIC 3052 Australia P +61 1300 11 8247 F (03) 8341 6212 Screening is available to all pregnant women W vcgs.org.au in Victoria. At the time of your Combined First Trimester Screen (CFTS) for Down syndrome, simply have your doctor select the pre-eclampsia screening option on the VCGS test request form. HOW DO I GET MY RESULTS? Pre-eclampsia A copy of your results will be sent to your screening in pregnancy referring doctor. You must contact your doctor Knowing your risk can protect your for your test result. When requested alongside baby's health. the CFTS, results are usually available within 3 working days of the 12 week ultrasound report being received by the laboratory. HOW MUCH WILL IT COST? There is some out of pocket cost for the CFTS test as it is not all covered by Medicare. There will be an additional cost for PE screening. See our website for details. Contact us WHERE CAN I GET MORE INFORMATION? For queries about PE screening, contact You can discuss pre-eclampsia with your Maternal Serum Screening: doctor, midwife or obstetrician. P 1300 934 355 F (03) 8341 6389 Better Health Channel: W vcgs.org.au/mss betterhealth.vic.gov.au/health/healthyliving/ pregnancy-pre-eclampsia * References Australian Action on Pre-Eclampsia: Rolnik, Daniel L., et al, 2017. Aspirin versus Placebo in Pregnancies at P (03) 9330 0441 W aapec.org.au High Risk for Preterm Preeclampsia. N Engl J Med. 377(7):613-622. MSS-W-259 v4 17/09/2018 What is pre-eclampsia? What does screening Screen negative result Pre-eclampsia (PE) is high blood pressure involve? A screen negative result means you are caused by pregnancy. It is one of the most unlikely to develop early-onset pre- Screening for early-onset pre-eclampsia is common and life threatening conditions eclampsia. A negative screen however, does an optional test that is performed alongside occurring in pregnancy. not mean you definitely will not develop pre- Combined First Trimester Screening (CFTS). eclampsia. With this screen result, you will • 1 in 20 pregnant women are affected • Screening uses the same blood as your continue to receive normal prenatal care. by pre-eclampsia CFTS test • Early screening allows for early intervention, • You must opt-in for PE screening on the which can protect your baby’s health Screen positive result CFTS test request form Screening during the first trimester can If you screen positive for early-onset pre- Screening requires: identify women at increased risk for eclampsia, close monitoring during your early-onset pre-eclampsia. Interventions pregnancy is recommended. The chance you A blood test between 11 to 13+6 weeks include low-dose aspirin and early delivery will develop pre-eclampsia is low, but your to measure serum pregnancy-associated depending on gestation. Without treatment, baby’s growth will be checked carefully. plasma protein-A (PAPP-A) and placental pre-eclampsia may affect the normal growth growth factor (PIGF) in maternal blood. of the baby. Why is aspirin effective? The blood test results are combined with RISK FACTORS FOR PRE-ECLAMPSIA? maternal blood pressure, maternal weight Low doses of aspirin during pregnancy may The risk factors for PE include: and family history information to provide reduce the risk of early-onset pre-eclampsia*. • Maternal and paternal family history a result. Aspirin is thought to prevent problems in the placenta that cause pre-eclampsia and affect • Previous pregnancy with PE the normal growth of a baby. • Multiple pregnancy (e.g. twins) Maternal history Aspirin treatment before 16 weeks in high • Maternal age (over 40 years) + risk women, can delay or even prevent the • Body Mass Index (BMI over 30) Maternal weight Screen negative early-onset of pre-eclampsia. Being able to • Pre-existing high blood pressure, + usual prenatal delay pre-eclampsia gives the baby more care diabetes, smoking or kidney disease Blood pressure results time to grow and develop (by avoiding an early delivery). • Systemic inflammation + Screen positive • Ethnic origin monitoring & Ultrasound treatment + Blood test.
Recommended publications
  • Incidence of Eclampsia with HELLP Syndrome and Associated Mortality in Latin America
    International Journal of Gynecology and Obstetrics 129 (2015) 219–222 Contents lists available at ScienceDirect International Journal of Gynecology and Obstetrics journal homepage: www.elsevier.com/locate/ijgo CLINICAL ARTICLE Incidence of eclampsia with HELLP syndrome and associated mortality in Latin America Paulino Vigil-De Gracia a,⁎, José Rojas-Suarez b, Edwin Ramos c, Osvaldo Reyes d, Jorge Collantes e, Arelys Quintero f,ErasmoHuertasg, Andrés Calle h, Eduardo Turcios i,VicenteY.Chonj a Critical Care Unit, Department of Obstetrics and Gynecology, Complejo Hospitalario de la Caja de Seguro Social, Panama City, Panama b Critical Care Unit, Clínica de Maternidad Rafael Calvo, Cartagena, Colombia c Department of Gynecology and Obstetrics, Hospital Universitario Dr Luis Razetti, Barcelona, Venezuela d Unit of Research, Department of Gynecology and Obstetrics, Hospital Santo Tomás, Panama City, Panama e Department of Gynecology and Obstetrics, Hospital Regional de Cojamarca, Cajamarca, Peru f Department of Gynecology and Obstetrics, Hospital José Domingo de Obaldía, David, Panama g Unit of Perinatology, Department of Gynecology and Obstetrics, Instituto Nacional Materno Perinatal, Lima, Peru h Department of Gynecology and Obstetrics, Hospital Carlos Andrade Marín, Quito, Ecuador i Unit of Research, Department of Gynecology and Obstetrics, Hospital Primero de Mayo de Seguridad Social, San Salvador, El Salvador j Department of Gynecology and Obstetrics, Hospital Teodoro Maldonado Carbo, Guayaquil, Ecuador article info abstract Article history: Objective: To describe the maternal outcome among women with eclampsia with and without HELLP syndrome Received 7 July 2014 (hemolysis, elevated liver enzymes, and low platelet count). Methods: A cross-sectional study of women with Received in revised form 14 November 2014 eclampsia was undertaken in 14 maternity units in Latin America between January 1 and December 31, 2012.
    [Show full text]
  • Vitamin D, Pre-Eclampsia, and Preterm Birth Among Pregnancies at High Risk for Pre-Eclampsia: an Analysis of Data from a Low-Dos
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author BJOG. Author Manuscript Author manuscript; Manuscript Author available in PMC 2021 January 29. Published in final edited form as: BJOG. 2017 November ; 124(12): 1874–1882. doi:10.1111/1471-0528.14372. Vitamin D, pre-eclampsia, and preterm birth among pregnancies at high risk for pre-eclampsia: an analysis of data from a low- dose aspirin trial AD Gernanda, HN Simhanb, KM Bacac, S Caritisd, LM Bodnare aDepartment of Nutritional Sciences, The Pennsylvania State University, University Park, PA, USA bDivision of Maternal-Fetal Medicine, Magee-Women’s Hospital and Department of Obstetrics, Gynecology and Reproductive Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA cDepartment of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA dDepartment of Obstetrics, Gynecology and Reproductive Sciences and Department of Pediatrics, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA eDepartments of Epidemiology and Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh Graduate School of Public Health and School of Medicine, Pittsburgh, PA, USA Abstract Objective—To examine the relation between maternal vitamin D status and risk of pre-eclampsia and preterm birth in women at high risk for pre-eclampsia. Design—Analysis of prospectively collected data and blood samples from a trial of prenatal low- dose aspirin. Setting—Thirteen sites across the USA. Population—Women at high risk for pre-eclampsia. Methods—We measured 25-hydroxyvitamin D [25(OH)D] concentrations in stored maternal serum samples drawn at 12–26 weeks’ gestation (n = 822). We used mixed effects models to Correspondence: LM Bodnar, University of Pittsburgh Graduate School of Public Health, A742 Crabtree Hall, 130 DeSoto St, Pittsburgh, PA 15261, USA.
    [Show full text]
  • Policy of Interventionist Versus Expectant Management of Severe
    WHO recommendations Policy of interventionist versus expectant management of severe pre-eclampsia before term WHO recommendations Policy of interventionist versus expectant management of severe pre-eclampsia before term WHO recommendations: policy of interventionist versus expectant management of severe pre-eclampsia before term ISBN 978-92-4-155044-4 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. WHO recommendations: policy of interventionist versus expectant management of severe pre-eclampsia before term. Geneva: World Health Organization; 2018.
    [Show full text]
  • Ophthalmic Associations in Pregnancy
    CLINICAL Ophthalmic associations in pregnancy Queena Qin, Celia Chen, Sudha Cugati PREGNANCY RESULTS in various physiological variation in pregnancy.2 It normally changes in the female body, including in fades slowly after pregnancy and does the eyes. A typical pregnancy results in not need active intervention. Background A range of ocular pathology exists cardiovascular, pulmonary, metabolic, • Cornea – corneal thickness, curvature during pregnancy. Some pre-existing eye hormonal and immunological changes. and sensitivity may be altered during conditions, such as diabetic retinopathy, Hormonal changes occur, with a rise of pregnancy. Corneal thickness and can be exacerbated during pregnancy. oestrogen and progesterone levels to curvature can increase in pregnancy, Other conditions manifest for the first suppress the menstrual cycle.1 especially in the second and third time during pregnancy as a result of The eye, an end organ, undergoes trimesters, and return to normal in complications such as pre-eclampsia changes during pregnancy. Some of the postpartum period.3 Patients who and eclampsia. Early recognition and understanding of the management of these changes exacerbate pre-existing wear contact lenses may experience ophthalmic conditions is crucial. eye conditions, while other conditions intolerance to the use of contact lenses. manifest for the first time during Pregnant women should be advised Objective pregnancy. Early recognition and to delay obtaining a new prescription The aim of this article is to discuss the understanding of management of for glasses or undergoing a contact physiological and pathological changes in the eyes of pregnant women. ophthalmic conditions during pregnancy lens fitting until after delivery. Laser Pathological changes are sub-divided is crucial for the primary care physician.
    [Show full text]
  • Pre-Eclampsia and High Blood Pressure During Pregnancy
    Pre-eclampsia and High Blood Pressure During Pregnancy What is high blood pressure? A blood pressure measurement is usually recorded as two numbers, Blood pressure is the force that pushes against your blood vessel such as 120 over 80 (120/80). High blood pressure is also called walls each time your heart squeezes and relaxes to pump the blood hypertension. Hypertension is diagnosed when either the top or the through your body. Blood pressure measurement is a very useful bottom number is higher than normal. way to monitor the health of your cardiovascular system (heart and blood vessels). Why is blood pressure important develops, it does not go away until after the baby is born. Women with pre-eclampsia may require an earlier delivery, during pregnancy? either by labour induction or caesarean section, in order to During pregnancy, very high blood pressure (severe hypertension) protect the health of themselves and their baby. In some cases, can cause complications for both you and your baby, including: pre-eclampsia can develop after childbirth and you should • Poor growth of your baby – due to low nutrition and oxygen alert your doctor or midwife of any concerns you may have supply from the placenta after your baby is born. • Prematurity – if early delivery (before 37 weeks) is required to protect the health of you or your baby • Placental abruption – the placenta may prematurely separate from the wall of the uterus (womb), leading to bleeding and the need for an emergency birth in some cases • Pre-eclampsia – a condition involving high blood pressure and abnormal function in one or more organs during pregnancy What are the different types of high blood pressure that affect pregnant women? 1.
    [Show full text]
  • Shoulder Dystocia Abnormal Placentation Umbilical Cord
    Obstetric Emergencies Shoulder Dystocia Abnormal Placentation Umbilical Cord Prolapse Uterine Rupture TOLAC Diabetic Ketoacidosis Valerie Huwe, RNC-OB, MS, CNS & Meghan Duck RNC-OB, MS, CNS UCSF Benioff Children’s Hospital Outreach Services, Mission Bay Objectives .Highlight abnormal conditions that contribute to the severity of obstetric emergencies .Describe how nurses can implement recommended protocols, procedures, and guidelines during an OB emergency aimed to reduce patient harm .Identify safe-guards within hospital systems aimed to provide safe obstetric care .Identify triggers during childbirth that increase a women’s risk for Post Traumatic Stress Disorder and Postpartum Depression . Incorporate a multidisciplinary plan of care to optimize care for women with postpartum emergencies Obstetric Emergencies • Shoulder Dystocia • Abnormal Placentation • Umbilical Cord Prolapse • Uterine Rupture • TOLAC • Diabetic Ketoacidosis Risk-benefit analysis Balancing 2 Principles 1. Maternal ‒ Benefit should outweigh risk 2. Fetal ‒ Optimal outcome Case Presentation . 36 yo Hispanic woman G4 P3 to L&D for IOL .IVF Pregnancy .3 Prior vaginal births: 7.12, 8.1, 8.5 (NCB) .Late to care – EDC ~ 40-41 weeks .GDM Type A2 – somewhat uncontrolled .4’11’’ .Hx of Lupus .BMI 40 .Gained ~ 40 lbs during pregnancy Question: What complication is she a risk for? a) Placental abruption b) Thyroid Storm c) Preeclampsia with severe features d) Shoulder dystocia e) Uterine prolapse Case Presentation . 36 yo Hispanic woman G4 P3 to L&D for IOL .IVF Pregnancy .3
    [Show full text]
  • Study of the Placental Attachment of Funiculus
    International Journal of Anatomy and Research, Int J Anat Res 2017, Vol 5(1):3535-40. ISSN 2321-4287 Original Research Article DOI: https://dx.doi.org/10.16965/ijar.2017.107 STUDY OF THE PLACENTAL ATTACHMENT OF FUNICULUS UMBILICALIS IN NORMAL AND PRE-ECLAMPTIC PREGNANCIES AND ITS EFFECTS ON BIRTH WEIGHT Ankit Jain *1, Sonia Baweja 2, Rashmi Jain 3. *1 M.S., Ex. Resident, Department of Anatomy, Gandhi Medical College, Bhopal (M.P.), India. 2 M.S., Associate Professor, Department of Anatomy, Gandhi Medical College, Bhopal (M.P.), India. 3 M.D., Lab Head, Consultant Pathologist, SRL Diagnostics Ltd, Malviya Nagar, Bhopal (M.P.), India. ABSTRACT Introduction: Abnormalities in the insertion of umbilical cord is associated with a number of complications in pregnancy and these complications may adversely affect the fetus. The aim of this study was to evaluate the variations in the attachment of umbilical cord in normal and pre-eclamptic pregnancies and to assess the effects of variable cord insertions on fetal birth weight. Materials and Methods: Seventy placentae each of normotensive and pre-eclamptic pregnancies were studied (n=140). After delivery, weight of the baby was recorded by using weighing machine and the attachment of umbilical cord on placenta was observed. Results: In the present study, commonest site of insertion of umbilical cord was central (60%) in normal pregnancies, whereas in pre-eclamptic pregnancies, a common site of insertions of umbilical cord were central (37.14%) and/or eccentric (34.28%). Marginal cord insertions were found 2.11 times more in pre-eclamptic pregnancies as compared to normal pregnancies.
    [Show full text]
  • Common Skin Changes During Pregnancy
    EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY Information Leaflet for Patients COMMON SKIN CHANGES DURING PREGNANCY The aim of this leaflet This leaflet is designed to help you understand more about skin changes during pregnancy. It tells you about some of the most common, usually harmless but sometimes unpleasant skin changes, and explains what you can do to help them. COMMON SKIN What are common skin changes during pregnancy? Skin changes during pregnancy include: CHANGES 1. stretch marks (striae) DURING 2. skin tags 3. changes in hair growth PREGNANCY 4. spider veins and varicose veins 5. darkening of areas of your skin (melasma or cloasma) 6. pimple breakouts (acne) - information in a separate leaflet 7. darkening of moles and freckles - information in a separate leaflet. What are stretch marks (striae)? What are skin tags (fibroma Stretch marks (also called striae) are linear pendulum, acrochordon)? marks that most often develop over the Skin tags are very small, 1-5 mm, loose, breasts, abdomen, hips, and thighs. They polyp-like, skin-coloured growths of skin begin as reddish purple lines and with that usually appear under your arms or time, they become white atrophic (wrinkled) breasts. The increased appearance of skin scars. They are very common in pregnancy, tags during pregnancy is hormonally- occurring in up to 50% to 90% of pregnant induced in areas exposed to mechanical women. They are usually asymptomatic, but irritation. They may disappear after delivery. rarely may cause burning and itching. If they still persist, these tiny tags can be Stretch marks are caused by stretching removed by your dermatologist.
    [Show full text]
  • Managing an Eclamptic Patient
    BEST PRACTICES FOR DIAGNOSIS AND MANAGEMENT OF PREECLAMPSIA OBGMANAGEMENT Managing Baha M. Sibai, MD Professor and Chairman Department of Obstetrics an eclamptic patient and Gynecology, University of Cincinnati Most Ob/Gyns have little experience managing acute eclampsia, but all maternity units and obstetricians need to be prepared to diagnose and manage this grave threat. n eclamptic convulsion is frighten- with generalized muscular contractions. ing to behold. First, the woman’s In the second phase, which lasts A face becomes distorted, and her about a minute, the muscles of the body eyes protrude. Then her face acquires a alternately contract and relax in rapid congested expression, and foam may succession. This phase begins with the exude from her mouth. Breathing stops. muscles of the jaw and rapidly encom- Because eclampsia is so frightening, passes eyelids, other facial muscles, and the natural tendency is to try to stop a con- body. If the tongue is unprotected, the vulsion, but this is not the wisest strategy. woman often bites it. Rather, the foremost priorities are to Coma sometimes follows the convul- avoid maternal injury and support cardio- sion, and deep, rapid breathing usually IN THIS ARTICLE vascular functions. How to do this, and begins as soon as the convulsion stops. In how to prevent further convulsions, moni- fact, maintaining oxygenation typically is ❙ Signs and tor and deliver the fetus, and avert compli- not a problem after a single convulsion, symptoms cations are the focus of this article. and the risk of aspiration is low in a well Page 40 Since eclampsia may be fatal for both managed patient.
    [Show full text]
  • Simmomtm Birthing Simulation Solutions
    Improving maternal and neonatal care SimMomTM Birthing Simulation Solutions www.laerdal.com/simmom Innovative simulation Improving patient safety Preventing adverse outcomes during birth Simulation has gathered increasing acceptance over the Simulation training is unique in its ability to facilitate effective years as an integral part of healthcare training and as a team training. By bringing together multi-disciplinary fundamental approach to help improve patient safety. healthcare professionals in a simulation to rehearse both common birthing scenarios and emergency critical incidents; In the field of obstetrics, research into suboptimal patient early recognition of birth complications, correct diagnosis outcomes have identified the following key contributory and rapid, coordinated action from the delivery team can factors: confusion in roles and responsibilities; lack of cross be perfected for improved outcomes. monitoring; failure to prioritize and perform clinical tasks in a structured, coordinated manner; poor communication and lack of organizational support. Reference : The Joint Commission, 2004, Draycott et al. 2009 2 Simulation by Laerdal and Limbs & Things SimMomTM A complete solution A progressive partnership SimMomTM is an advanced full-body birthing simulator with By integrating the strengths of the PROMPT birthing accurate anatomy and functionality. SimMom has been simulator from Limbs & Things with the ALS Simulator developed to provide you with a comprehensive simulation from Laerdal, SimMom provides anatomical accuracy and solution to support multi-disciplined staff in obstetric and authentic simulation experiences that together, facilitate midwifery care, enabling refinement of individual skills and valuable learning experiences for a wide range of midwifery team performance. and obstetric skills. With a range of Technical and Educational Services as well as pre-programmed scenarios to ease educator preparation time, SimMom is the optimal simulation experience.
    [Show full text]
  • Gestational Hypertension & Pre-Eclampsia
    Journal of Labor and Childbirth Gestational hypertension & pre-eclampsia Introduction • First, we talk about the definitions • When, how, why the disease occurs? • How diagnose, how to treat and how to prevent according to guidelines Moatasem Bellah Al Farrah • This lecture is to know about the disease in new way. DUMMAR Medical Center, Syria Background : Prompt identification and appropriate management of Hypertensive Disorders in Pregnancy (HDP) are essential for optimal outcomes because HDP: Biography • Are associated with severe maternal obstetric complications and increased maternal mortality risk Moatasem Bellah Al Farrah is a mem- ber of Syrian Doctors Association. He is • Lead to preterm delivery, fetal intrauterine growth restriction, low birthweight and perinatal death currently working as an assistant profes- sor in Dummar Medical center and Red Study made between 2006 and 2008 showed: 70 maternal deaths, showing leading causes of death to Crescent. He is also a member in British be: hypertension (20%), haemorrhage (19%) and embolism (17%). Chronic illness, obesity and prenatal Society for Gynecological Endoscopy, International Urogynecology Associa- risk factors were identified as important circumstances in the cases reviewed. tion, British Society for Urogynecolo- Definition and classification of Hypertensive Disorders in Pregnancy (HDP) gy. His professional interests focus on PCOS and Endometriosis Researches. Hypertensive Disorders in Pregnancy are comprised of a spectrum of disorders typically classified into categories
    [Show full text]
  • Aspirin for the Prevention of Preterm and Term Preeclampsia: Systematic Review and Metaanalysis Stephanie Roberge, Phd; Emmanuel Bujold, MD, Msc; Kypros H
    Systematic Reviews ajog.org Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis Stephanie Roberge, PhD; Emmanuel Bujold, MD, MSc; Kypros H. Nicolaides, MD reeclampsia is a major cause of P maternal and fetal morbidity and OBJECTIVE DATA: Metaanalyses of randomized controlled trials have reported contra- death.1 The adverse consequences of dictory results about the effect of aspirin in the prevention of preeclampsia, both in terms preeclampsia are particularly evident if it of the gestational age at the onset of treatment and the dose of the drug. The controversy is associated with preterm birth. Several may be resolved by a metaanalysis that includes several recently published trials and randomized studies investigated the particularly the large Combined Multimarker Screening and Randomized Patient Treat- possibility of preventing preeclampsia by ment with Aspirin for Evidence-based Preeclampsia Prevention trial and by examination the prophylactic use of aspirin, with of whether there is a difference of the effect of aspirin on preterm vs term preeclampsia. 2,3 contradictory results. STUDY: We performed a systematic review and metaanalysis that evaluated the pro- A metaanalysis of individual- phylactic effect of aspirin during pregnancy. participant data reported that the effect STUDY APPRAISAL AND SYNTHESIS METHODS: We completed a literature search of aspirin in the reduction of pre- through PubMed, Cinhal, Embase, Web of Science, and Cochrane library from 1985 to eclampsia was 10%; this was not affected June 2017. Relative risks with random effect were calculated with their 95% confidence by the gestational age at the onset of intervals. 3 therapy or the dose of aspirin.
    [Show full text]